Wagh BR, Godbole DD, et al. Identification and Assessment of Potential Drug–Drug Interactions in Intensive Care Unit Patients. Indian J Crit Care Med 2019;23(4):170–174.
Vanham D, Spinewine A, Hantson P, et al. Drug-drug interactions in the intensive care unit: Do they really matter? J Crit Care 2017;38:97–103.
Baniasadi S, Farzanegan B, Alehashem M. Important drug classes associated with potential drug-drug interactions in critically ill patients: highlights for cardiothoracic intensivists. Ann Intensive Care 2015;5(1):44.
Martinbiancho J, Zuckermann J, Dos Santos L, et al. Profile of drug interactions in hospitalized children. Pharm Pract (Granada) 2007;5(4):157–161.
Malfará M, Pernassi M, Aragon D, et al. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit. Int J Clin Pharm. 2018;40(3):513–519.
Uijtendaal EV, van Harssel LL, Hugenholtz GW, et al. Analysis of potential drug-drug interactions in medical intensive care unit patients. Pharmacotherapy 2014;34(3):213–219.
Smithburger PL, Kane-Gill SL, Seybert AL. Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients
